ChemoCentryx Inc
Change company Symbol lookup
Select an option...
CCXI ChemoCentryx Inc
QIAN Qiansui International Group Co Ltd
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
MGP MGM Growth Properties LLC
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving the rest of the immune system intact. Its late stage compounds include Avacopan (CCX168) and CCX140. Avacopan (CCX168) is an orally administered complement inhibitor targeting the C5a receptor (C5aR), and is being developed for orphan and rare diseases, including anti-neutrophil cytoplasmic auto-antibody associated vasculitis (AAV); atypical hemolytic uremic syndrome (aHUS), and complement 3 glomerulopathy (C3G). CCX140 is an orally administered inhibitor of the chemokine receptor known as C-C chemokine receptor type 2 (CCR2), in development for diabetic nephropathy (DN), a form of chronic kidney disease (CKD), and for focal segmental glomerulosclerosis (FSGS).

Closing Price
$12.18
Day's Change
0.64 (5.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.73
Day's Low
12.02
Volume
(Heavy Day)
Volume:
7,433,867

10-day average volume:
2,833,528
7,433,867
  • Prev Close
    11.54
  • Today's Open
    13.06
  • Day's Range
    12.02-13.73
  • Avg Vol (10-day)
    2.8M
  • Last (time)
    4:00p ET 06/11/21
  • Last (size)
    3.1K
  • 52-Wk Range
    9.53 - 70.29
    LowHigh
  • (02/09/21 - 05/25/21)
    27.81%
  • 125.4%
  • Market Cap
    849.5M
  • Shares Outstanding
    69.7M
  • -0.92
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 70.24
  • (% of float 05/28/21)
    5.91

Latest News

June 13, 2021
12:27 pm ET
Newsfile
June 12, 2021
4:40 pm ET
Newsfile
2:11 pm ET
Globe Newswire
11:05 am ET
Globe Newswire
June 11, 2021
10:00 pm ET
Globe Newswire
1:30 pm ET
BusinessWire
1:00 pm ET
PR Newswire
12:16 pm ET
Newsfile
11:35 am ET
PR Newswire
11:02 am ET
Accesswire
10:12 am ET
Accesswire
9:41 am ET
Newsfile
5:29 am ET
Newsfile
4:00 am ET
PR Newswire
June 10, 2021
10:31 pm ET
Newsfile
7:01 pm ET
Newsfile
5:30 pm ET
BusinessWire
5:26 pm ET
Accesswire
5:25 pm ET
Accesswire
4:45 pm ET
PR Newswire
2:36 pm ET
Accesswire
1:43 pm ET
Accesswire
10:12 am ET
Accesswire
9:40 am ET
Newsfile
5:41 am ET
Accesswire
June 09, 2021
11:02 pm ET
Globe Newswire
9:37 pm ET
Globe Newswire
1:32 pm ET
Newsfile
1:22 pm ET
BusinessWire
12:01 pm ET
BusinessWire
11:30 am ET
Globe Newswire
11:02 am ET
Accesswire
10:33 am ET
Newsfile
9:05 am ET
Accesswire
9:05 am ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.